Center-involved diabetic macular edema (ci-dme)

Clinical trials for Center-involved diabetic macular edema (ci-dme) explained in plain language.

Never miss a new study

Get alerted when new Center-involved diabetic macular edema (ci-dme) trials appear

Sign up with your email to follow new studies for Center-involved diabetic macular edema (ci-dme), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet finished but already full! 1

Gene therapy shot could end need for repeated eye needles in diabetes

Disease control Ongoing

This phase 2 trial tests RGX-314, a gene therapy given as a single injection into the eye, for people with diabetic retinopathy. The goal is to see if it can improve vision and reduce the need for frequent anti-VEGF injections. About 139 adults with diabetes-related eye damage ar…

Matched conditions: CENTER-INVOLVED DIABETIC MACULAR EDEMA (CI-DME)

Phase 2 • Sponsor: AbbVie • Aim: Disease control

Last updated Aug 21, 2026 00:00 UTC

Center-involved diabetic macular edema (ci-dme)

Get alerted when new Center-involved diabetic macular edema (ci-dme) trials appear

Gene therapy shot could end need for repeated eye needles in diabetes